Age-related changes in appendicular lean mass in males with Duchenne muscular dystrophy: A retrospective review.
Summer, SS; Wong, BL; Rutter, MM; Horn, PS; Tian, C; Rybalsky, I; Shellenbarger, KC; Kalkwarf, HJ.
Muscle and Nerve.
2021;
63:231-238.
Safety and efficacy of teriparatide treatment for severe osteoporosis in patients with Duchenne muscular dystrophy.
Nasomyont, N; Keefe, C; Tian, C; Hornung, L; Khoury, J; Tilden, JC; Hochwalt, P; Jackson, E; Rybalsky, I; Wong, BL; et al.
Osteoporosis International.
2020;
31:2449-2459.
Oral bisphosphonate treatment in patients with Duchenne muscular dystrophy on long term glucocorticoid therapy.
Tian, C; Wong, BL; Hornung, L; Khoury, JC; Rybalsky, I; Shellenbarger, KC; Rutter, MM.
Neuromuscular Disorders.
2020;
30:599-610.
Neurodevelopmental, behavioral, and emotional symptoms common in Duchenne muscular dystrophy.
Darmahkasih, AJ; Rybalsky, I; Tian, C; Shellenbarger, KC; Horn, PS; Lambert, JT; Wong, BL.
Muscle and Nerve.
2020;
61:466-474.
MRI vastus lateralis fat fraction predicts loss of ambulation in Duchenne muscular dystrophy.
Naarding, KJ; Reyngoudt, H; van Zwet, EW; Hooijmans, MT; Tian, C; Rybalsky, I; Shellenbarger, KC; Le Louer, J; Wong, BL; Carlier, PG; et al.
Neurology.
2020;
94:e1386-e1394.
Neurodevelopmental, behavioral, and emotional symptoms in Becker muscular dystrophy.
Lambert, JT; Darmahkasih, AJ; Horn, PS; Rybalsky, I; Shellenbarger, KC; Tian, C; Wong, BL.
Muscle and Nerve.
2020;
61:156-162.
Comparison of Pulmonary Function Decline in Steroid-Treated and Steroid-Naïve Patients with Duchenne Muscular Dystrophy.
Sawnani, H; Horn, PS; Wong, B; Darmahkasih, A; Rybalsky, I; Shellenbarger, KC; Tian, C; Rutter, MM; Simakajornboon, N; Amin, R; et al.
Journal of Pediatrics.
2019;
210:194-200.e2.
Low bone mineral density and fractures are highly prevalent in pediatric patients with spinal muscular atrophy regardless of disease severity.
Wasserman, HM; Hornung, LN; Stenger, PJ; Rutter, MM; Wong, BL; Rybalsky, I; Khoury, JC; Kalkwarf, HJ.
Neuromuscular Disorders.
2017;
27:331-337.
Long-Term Outcome of Interdisciplinary Management of Patients with Duchenne Muscular Dystrophy Receiving Daily Glucocorticoid Treatment.
Wong, BL; Rybalsky, I; Shellenbarger, KC; Tian, C; McMahon, MA; Rutter, MM; Sawnani, H; Jefferies, JL.
Journal of Pediatrics.
2017;
182:296-303.e1.
Bone health measures in glucocorticoid-treated ambulatory boys with Duchenne muscular dystrophy.
Tian, C; Wong, BL; Hornung, L; Khoury, JC; Miller, L; Bange, J; Rybalsky, I; Rutter, MM.
Neuromuscular Disorders.
2016;
26:760-767.